In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...